Full-Time
Updated on 8/4/2026
Operates hospitals and clinics; revenue cycle
No salary listed
Detroit, MI, USA
In Person
Bachelor's
See people who can refer or advise you
Tenet Healthcare operates a large network of hospitals and outpatient facilities across the United States, including 65 hospitals and about 500 other centers such as surgical hospitals, urgent care sites, and imaging centers. It also owns Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers, and other clients, helping them manage billing and payments and improve patient outcomes. The company earns revenue mainly from patient services and from Conifer’s administrative and financial services. Its goal is to deliver the right care, in the right place, at the right time, while improving patient outcomes and operational efficiency and serving as a trusted employer and partner.
Company Size
10,001+
Company Stage
IPO
Headquarters
Dallas, Texas
Founded
1967
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Professional Development Budget
Mental Health Support
Paid Sick Leave
Paid Holidays
Paid Vacation
Health Insurance
Flexible Work Hours
Tenet Healthcare stock surges after blockbuster Q2 beat. TIM BOHEN - UPDATED JUL. 25, 2026, 8:37 AM ET Tenet Healthcare Corporation stocks have been trading up by 17.17 percent, driven mainly by strong earnings and upbeat guidance. What traders need to know. * Q2 2026 adjusted EPS came in at $6.12 versus $4.26 consensus on $5.63B revenue, powered by strong same-store growth, tight cost control, and higher-acuity services. * Management lifted 2026 guidance to adjusted EPS of $20.30-$21.69 and revenue of $21.9B-$22.5B, with about $295M more EBITDA and $225M more free cash flow at the midpoint. * Share repurchase capacity increased by $2B after $1.04B bought back last quarter, leaving $2.13B available and targeting roughly a 6% reduction in share count at current prices. * The stock ripped more than 16-17% after the earnings release and guidance hike, strongly separating itself from a mostly flat healthcare tape. * Major banks including BofA, Barclays, Wells Fargo, UBS, and Guggenheim all stay positive on THC, with targets clustered roughly in the $231-$290 range. Weekly Update Jul 20 - Jul 24, 2026: On Saturday, July 25, 2026 Tenet Healthcare Corporation stock [NYSE: THC] is trending up by 17.17%! Discover the key drivers behind this movement as well as its expert analysis in the detailed breakdown below. Healthcare industry expert: Analyst sentiment - positive Tenet Healthcare (THC) is operating as a top-tier acute-care and ambulatory consolidator with sector-leading profitability: EBIT margin 18.6%, EBITDA margin 22.8%, and consolidated net margin 7.9% on $21.3B revenue, all above typical hospital peers. Returns on equity (38-49%) and capital (10-25%) are exceptional, powered by strong asset turnover and mix shift to higher-acuity and ASC volumes. Leverage is elevated (total debt/equity 2.7x; LT debt/cap ~73%) but comfortably serviced (interest coverage 5.9x) and supported by $1.46B quarterly FCF, modest capex, and aggressive buybacks at a single-digit P/E (~9x) and 0.7x sales. The stock's weekly tape shows a powerful breakout and follow-through: from ~195 to a spike high near 233, closing at 233.2, confirming a vertical expansion in range with clear institutional demand. Intraday 5-minute candles post-earnings show repeated high-volume buying above 220 and shallow pullbacks, indicating strong dip support rather than distribution. Dominant trend is firmly bullish. A key actionable level is $220: use it as primary support and stop zone for swing longs, with fresh entries on low-volume pullbacks toward 225-228 targeting continuation above recent highs. Fundamentals, revisions, and positioning place Tenet ahead of both the Healthcare sector and Healthcare Providers & Services peers on growth, margins, and FCF conversion. Q2 results massively beat expectations, guidance for 2026 EPS and EBITDA moved materially above Street, and multiple banks raised targets into the $270-290 range as shares jumped >15%. Expanded $2B buyback plus $2.13B remaining capacity adds structural support. I see upside toward $275-285 over 12 months, with key support at $220 and interim resistance near $250. Quick financial overview. Tenet Healthcare Corporation (THC) just printed the kind of quarter that resets expectations. Q2 2026 adjusted EPS of $6.12 not only smashed the $4.26 consensus, it also marked a sharp jump from last year's $4.02. Revenue of $5.63B beat estimates and was backed by higher same-facility revenue and better hospital margins, not just accounting noise. For traders, that matters: strong price and volume in the business usually supports strong price and volume in the stock. The guidance move is just as important. THC now sees 2026 adjusted EPS at $20.30-$21.69 and revenue at $21.9B-$22.5B, with about $295M more adjusted EBITDA and $225M more free cash flow at the midpoint. Key ratios back up this earnings power: EBIT margin sits around 18.6%, EBITDA margin roughly 22.8%, and return on equity is very high near 48.5%. The balance sheet is still leveraged with total debt-to-equity at 2.74, but interest coverage of 5.9 and free cash flow of about $1.46B for the recent quarter help support that load. On valuation, THC trades around a 9.2 P/E and about 0.7 times sales, with price-to-free-cash-flow near 2.5, which is low for a name delivering this type of growth. The chart confirms that traders are re-rating the stock. Weekly data show a breakout from the high-$190s into the low-$230s, with a huge expansion in the range once earnings hit: a move from roughly $199 to a spike near $233-$235 in just days, and an intraday high around $246 on the post-earnings session before closing near $233. That kind of wide intraday bar after a gap up usually signals heavy participation and sets up a new trading range for the coming weeks. Conclusion. This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Its coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, StocksToTrade, Inc. break down the events that can spark significant price action. Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead. Once your watchlist is set, take the next step and trade with confidence using StocksToTrade's robust platform. Don't miss out - grab your 14-day trial for just $7 and experience the edge you need to thrive in today's fast-paced markets. 2x opportunities. Every Monday. Every week on Monday morning... I've been targeting gains up to 149% before lunch. Yes - 2x opportunities. Every Monday. I call it the Money Monday trade... And if you get it right, it could set you up for the whole week!
Tenet Healthcare shares surged 14.6% in premarket trading on Friday after the Dallas-based hospital operator delivered stronger-than-expected second-quarter results and raised its full-year outlook. The company reported earnings of $6.12 per share, well above the $4.26 consensus estimate. Revenue reached $5.63 billion, exceeding expectations of $5.43 billion. Tenet also substantially increased its 2026 guidance, now expecting earnings per share between $20.30 and $21.69, ahead of the previous consensus of $17.81. Revenue guidance was lifted to between $21.9 billion and $22.5 billion. The results come as investors have grown cautious toward hospital operators. Earlier this earnings season, HCA Healthcare lowered its full-year profit outlook after reporting pressure from unfavourable payer mix.
Tenet Healthcare lifts 2026 outlook as EBITDA jumps, margins strengthen across segments. 24 July 2026, 11:07 AM Q2 EBITDA exceeds expectations; outlook raised on back of broad-based growth. Tenet Healthcare (NYSE: THC) delivered a strong second quarter for 2026, reporting a consolidated adjusted EBITDA of $1.30 billion - up 16.3% over last year - and pushing margins to 23.2%. Management's improved 2026 outlook now calls for consolidated adjusted EBITDA in the range of $4.83-$5.03 billion, a $295 million increase at the midpoint. Adjusted free cash flow guidance also rose, now expected between $2.73-$3.03 billion for the year. These numbers not only surpassed prior internal targets but also pointed to broad operational strength as both the hospital and ambulatory segments showed material improvement. Margin expansion and segment details highlight management's execution. Tenet's improved profitability was visible across its two main segments. The hospital segment's EBITDA margin rose to 18.0% from 15.6% in the prior year, aided by strong growth in same-facility revenue and disciplined expense management. Ambulatory care margins remained industry-leading at 39.0%, as operational leverage offset slight softness in surgical case volumes. Management noted that strategic investments in high-acuity services and innovation continue to drive this margin expansion despite payer mix headwinds. | Segment | Q2 2026 Adjusted EBITDA ($M) | Q2 2026 EBITDA Margin (%) | YoY EBITDA Growth (%) | | Ambulatory Care | 542 | 39.0 | 8.8 | | Hospital Operations & Services | 762 | 18.0 | 22.3 | | Total | 1,304 | 23.2 | 16.3 | Shareholder returns accelerate with $2 billion share repurchase boost. In addition to robust financials, Tenet's board authorized a $2.0 billion expansion of its share buyback program, bringing the total authorization to $2.13 billion as of late July 2026. The company repurchased $1.36 billion in shares over the first six months of the year, reflecting the management's confidence in Tenet's long-term trajectory and strong cash generation. Tenet's net debt to adjusted EBITDA was 2.33x at quarter-end, remaining at a manageable level. Operating trends support upbeat guidance. Both segments delivered healthy top-line growth: ambulatory net revenues grew 9.3% year-over-year, driven by higher net revenue per case (+6.3%) and continued expansion in service lines. Hospitals benefited from improved admissions (+2.3%) and disciplined cost control despite some pressured payer mix. The company's full-year forecast expects further gains in net operating revenue, higher adjusted EBITDA margins (22.1-22.4%), and solid cash flows to support ongoing investments and capital returns. | Key Outlook Metrics (FY 2026) | Updated Range ($B) | Prior Midpoint ($B) | Change ($M) | | Adjusted EBITDA | 4.83 - 5.03 | 4.635 | +295 | | Adjusted Free Cash Flow | 2.73 - 3.03 | 2.8 | +225 | Key takeaways: operational discipline and strategic focus drive upside. Tenet Healthcare's strong second quarter and raised 2026 outlook point to successful execution of its growth and efficiency strategy. Margin improvements across both hospital and ambulatory segments highlight a focus on service mix, cost management, and investments in higher-acuity care. With balance sheet flexibility and an enhanced buyback program, Tenet appears well-positioned to capitalize on evolving industry dynamics in the coming quarters. Investors may want to monitor further updates on capital deployment and margin stability as management continues its webcast discussion and publishes additional materials on its investor relations site. Contact Information: If you have feedback or concerns about the content, please feel free to reach out to Market Chameleon via email at [email protected]. About the Publisher - Marketchameleon.com: Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. Market Chameleon leverage extensive data, models, and analytics to provide valuable insights into these markets. Its primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards. NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com. The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information. Disclosure: This article was generated with the assistance of AI
Legacy Capital Group California Inc. trims holdings in Tenet Healthcare Corporation $THC. July 16, 2026 Key points. * Legacy Capital Group California sharply cut its Tenet Healthcare position by 85.4% in the first quarter, selling 8,315 shares and leaving it with 1,418 shares worth about $268,000. * Tenet Healthcare reported better-than-expected earnings for the quarter, posting EPS of $4.82 versus estimates of $4.21, while revenue rose 2.6% year over year to $5.37 billion. * Analysts remain broadly positive on the stock, with 18 Buy ratings and 4 Hold ratings; the consensus view is Moderate Buy with an average price target of $245.37. * Five stocks to consider instead of Tenet Healthcare. Legacy Capital Group California Inc. decreased its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 85.4% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 1,418 shares of the company's stock after selling 8,315 shares during the period. Legacy Capital Group California Inc.'s holdings in Tenet Healthcare were worth $268,000 as of its most recent SEC filing. A number of other hedge funds have also added to or reduced their stakes in the stock. Archer Investment Corp bought a new stake in shares of Tenet Healthcare during the first quarter valued at about $113,000. State of Michigan Retirement System grew its stake in Tenet Healthcare by 1.9% during the first quarter. State of Michigan Retirement System now owns 21,193 shares of the company's stock valued at $3,999,000 after acquiring an additional 400 shares in the last quarter. Principal Financial Group Inc. increased its holdings in Tenet Healthcare by 3.8% during the 1st quarter. Principal Financial Group Inc. now owns 196,092 shares of the company's stock worth $37,005,000 after acquiring an additional 7,127 shares during the period. Applied Finance Capital Management LLC lifted its stake in Tenet Healthcare by 3.8% in the 1st quarter. Applied Finance Capital Management LLC now owns 1,644 shares of the company's stock worth $310,000 after purchasing an additional 60 shares in the last quarter. Finally, Diversify Wealth Management LLC grew its position in shares of Tenet Healthcare by 31.0% during the 1st quarter. Diversify Wealth Management LLC now owns 3,409 shares of the company's stock valued at $614,000 after purchasing an additional 806 shares in the last quarter. Hedge funds and other institutional investors own 95.44% of the company's stock. Tenet Healthcare trading up 4.6%. NYSE THC opened at $192.16 on Thursday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. The stock's 50-day simple moving average is $184.15 and its two-hundred day simple moving average is $197.51. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a market capitalization of $16.55 billion, a price-to-earnings ratio of 9.99, a PEG ratio of 1.51 and a beta of 1.27. Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $4.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.21 by $0.61. The firm had revenue of $5.37 billion during the quarter, compared to analysts' expectations of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company's revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $4.36 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. Research analysts forecast that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year. Wall Street analysts forecast growth. A number of equities research analysts recently issued reports on THC shares. TD Cowen lowered their price objective on Tenet Healthcare from $242.00 to $233.00 and set a "buy" rating on the stock in a research report on Monday, June 22nd. Stephens decreased their target price on Tenet Healthcare from $275.00 to $260.00 and set an "overweight" rating on the stock in a research note on Monday, May 4th. Morgan Stanley set a $254.00 price target on Tenet Healthcare in a report on Friday, May 1st. Robert W. Baird cut their price objective on Tenet Healthcare from $245.00 to $210.00 and set a "neutral" rating for the company in a report on Tuesday, May 5th. Finally, Weiss Ratings downgraded shares of Tenet Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Tuesday, June 2nd. Eighteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company's stock. According to MarketBeat, Tenet Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $245.37. Insider activity at Tenet Healthcare. In related news, Director Nadja West sold 3,000 shares of Tenet Healthcare stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total value of $532,050.00. Following the transaction, the director owned 24,805 shares in the company, valued at $4,399,166.75. This trade represents a 10.79% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the business's stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company's stock, valued at $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company's stock. About Tenet Healthcare. Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics. In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination. Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report). This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. Before you consider Tenet Healthcare, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list. While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Tenet Healthcare is increasingly focusing on growth through United Surgical Partners International (USPI), its ambulatory surgery centre network, as healthcare shifts toward lower-cost outpatient care. In the first quarter of 2026, USPI generated $484 million in adjusted EBITDA, up 6.1% year over year, with same-facility revenues rising 5.3%. Tenet invested $125 million during the quarter to acquire seven ASCs and open three new centres, completing nearly half its planned annual investment. The company posted double-digit growth in outpatient joint replacements, reflecting rising demand for higher-acuity procedures in outpatient settings. Competitors including Surgery Partners and HCA Healthcare are also expanding their ambulatory surgery networks to capitalise on the growing outpatient care market.